In humans, the biotransformation of cholesterol and its hydroxylated metabolites (oxysterols) by sulfonation is a fundamental process of great importance. Nevertheless, the sulfotransferase enzyme(s) that carries out this function has never been clearly identified. Cholesterol is a relatively poor substrate for the previously cloned hydroxysteroid sulfotransferase (HST), i.e. dehydroepiandrosterone (DHEA) sulfotransferase (HST1). Recently, cloning of a single human gene that encodes for two proteins related to HST1 was reported. These newly cloned sulfotransferases (HST2a and HST2b), while exhibiting sequence similarity to other members of the soluble sulfotransferase superfamily, also contain unique structural features. This latter aspect prompted an examination of their substrate specificity for comparison with HST1. Thus, HST1, HST2a, and HST2b were overexpressed as fusion proteins and purified. Furthermore, a novel procedure for the isolation of cholesterol and oxysterol sulfonates was developed that was used in association with HPLC to resolve specific sterol sulfonates. HST1 preferentially sulfonated DHEA and, to a lesser extent, oxysterols; whereas cholesterol was a negligible substrate. The reverse, however, was the case for the HST2 isoforms, particularly HST2b, which preferentially sulfonated cholesterol and oxysterols, in contrast to DHEA, which served as a poor substrate for this enzyme. RT-PCR analysis revealed distinct patterns of HST1, HST2a, and HST2b expression. It was particularly notable that both HST2 isoforms, but not HST1, were expressed in skin, a tissue where cholesterol sulfonation plays an important role in normal development of the skin barrier. In conclusion, substrate specificity and tissue distribution studies strongly suggest that HST2a and HST2b, in contrast to HST1, represent normal human cholesterol and oxysterol sulfotransferases. Furthermore, this study represents the first example of the sulfonation of oxysterols by a specific human HST.
A N INTERESTING DEVELOPMENT in recent years has been the realization that steroid sulfoconjugates are not merely metabolites produced for eventual elimination. There are now well-characterized biological effects attributable to steroid sulfonates that are distinct from the wellknown role of unconjugated steroids as ligands for nuclear receptors regulating gene expression. A prime example of the nongenomic action of steroid sulfonates involves regulation of the brain GABA A receptor, which regulates chloride channels, where the sulfonates of pregnenolone (C 21 ) and dehydroepiandrosterone (DHEA) (C 19 ) have been shown to be potent neuroexcitatory agents, by virtue of their antagonist action (1) . The extranuclear effects of steroid sulfonates, which are generally located at cell membranes, involve all classes of steroids, i.e. the C 21 , C 19 , and C 18 side-chain cleavage products of cholesterol (C 27 ). Interestingly, focus on the side-chain cleavage products of cholesterol, owing to their significant biological effects, has more recently shifted, to also include the C 27 hydroxylated metabolites of cholesterol. Several orphan nuclear hormone receptors regulating genes involved in cholesterol homeostasis have now been shown to be bound and activated by hydroxylated cholesterol metabolites or oxysterols (2) (3) (4) . Thus far, three C 27 hydroxylated cholesterol compounds, i.e. 24(S)-, 25-, and 25,26(R)-cholesterol (27-hydroxycholesterol) have been identified and their respective hydroxylase genes cloned (5) (6) (7) (8) . Additionally, similar to C 21 , C 19 , and C 18 steroids, C 27 oxysterols are also subject to sulfonation (9 -11) . Though the biological significance of the sulfonates of hydroxycholesterol metabolites has not been carefully addressed and is thus poorly understood, if the course of the smaller steroid sulfonate relatives is followed, an important role is likely to be eventually realized. On the other hand, there already exists an extensive literature on the biological significance of the sulfonate of cholesterol itself.
Cholesterol sulfonate is widely distributed (12) (13) (14) (15) (16) (17) (18) and circulates in plasma at concentrations ranging from 328 -924 g/100 ml, with a blood production rate of 35-163 mg/day (19) . Cholesterol sulfonate has been implicated in a wide variety of biological processes, e.g. regulation of cholesterol synthesis (20) , sperm capacitation (21), thrombin and plasmin activities (22) , and activation of protein kinase C isozymes (23) , particularly the isoform (24) . Furthermore, cholesterol sulfonate can serve as a substrate for adrenal (25) and ovarian (26) steroidogenesis. Cholesterol sulfonate plays an important, but unclear, role in the normal development and physiology of skin, where an epidermal cholesterol sulfate cycle has been described (27) . What is clear, however, is the pathogenic role of excessive cholesterol sulfonate depo-sition in the stratum corneum of the epidermis in the development of recessive X-linked ichthyosis (28) . Although the sulfonates of cholesterol and its hydroxylated metabolites are naturally occurring, the sulfotransferase enzyme(s) that produces them has not been clearly identified. In human liver, hydroxysteroid sulfotransferase (HST), commonly referred to as DHEA sulfotransferase, was suggested as the major enzyme to catalyze the sulfonation of cholesterol (29) . The complementary DNA (cDNA) for human DHEA sulfotransferase (HST1) was originally cloned from the liver (30 -32) and adrenal (33) . More recently, cDNAs of two novel human HST isoenzymes (HST2a and HST2b) were cloned from a placental cDNA library (34) . As part of a program to identify the specific sulfotransferase(s) that catalyzes the sulfonation of cholesterol and C 27 oxysterols, we evaluated the specificity of cloned human HST1, HST2a, and HST2b using novel techniques that permit an assessment of substrate preference. Our findings clearly indicate that the HST2 isoforms sulfonate cholesterol and other C 27 sterols, in preference to DHEA, and, whereas HST1 is distinguishable as a DHEA sulfotransferase.
Materials and Methods Materials
Cholesterol sulfate, 25-hydroxycholesterol, pyridine-SO 3 complex, and methylene blue were purchased from Sigma (St. Louis, MO). Sulfonated standards of 24(S)-and 27-hydroxycholesterol were prepared from either the free sterol or the 3-and 27-monoacetates (35) using pyridine-SO 3 complex (36) to yield the disulfonate and monosulfonate/ monoacetate, respectively. Removal of acetate groups by methanolic KOH yielded the respective 3-and 27-monosulfonates of 27-hydroxycholesterol. The 3-sulfonate of 25-hydroxycholesterol was prepared directly from the free sterol (37 
Expression and purification of human HST1, HST2a, and HST2b
To overexpress HST1 (GenBank accession no. U08024), HST2a (GenBank accession no. U92314), and HST2b (GenBank accession no. U92315) in Escherichia coli, the open reading frames of cDNAs were amplified by PCR using the templates SULT2A1-p91023, SULT2B1a-pCR3.1, and SULT2B1b-pCR 3.1, generously supplied by Dr. Richard M. Weinshilboum at the Department of Pharmacology, Mayo Medical School/ Mayo Clinic/Mayo Foundation, Rochester, MN. HST1 sense and antisense primers were, respectively, 5Ј-ATGTCGGACGATTTCTTA-TGGTTTG-3Ј and 5Ј-TTATTCCCATGGGAACAGCTC-3Ј. HST2a and HST2b sense primers were, respectively, 5Ј-GTCGACATGGCGTCTC-CCCCACCTTTCCAC-3Ј and 5Ј-GTCACAATGGACGGGCCCGCCGA-GCCCCAGATC-3Ј; both sense primers were paired with the common antisense primer 5Ј-GCGGCCGCTTATTATGAGGGTCGTGGGTG-CGG-3Ј. PCR products were isolated by the agarose gel purification method (QIAGEN, Santa Clarita, CA) and subcloned into a bacterial expression vector pCRT7/NT-TOPO (Invitrogen, San Diego, CA). Subclones containing the insert cDNA in the correct orientation were selected by PCR using T7 sense primer and gene-specific antisense primer. The bacterial expression constructs were used to transform BL21(DE3)pLysS cells (Stratagene). Transformed bacteria were grown in 50 ml LB broth with ampicillin, for 3 h at 37 C, and then overnight at 26 C. The overnight seed cultures were added to 1 l LB broth with ampicillin and were incubated at room temperature until A 600 reached 0.4 -0.8, at which time IPTG was added to a final concentration of 0.1 mm. Incubations were continued overnight at room temperature. Bacteria were harvested and pellets suspended in 5 ϫ (wt/vol) of chilled lysis buffer (50 mm sodium phosphate, 300 mm NaCl, 10 mm imidazole, pH 8.0) containing proteolytic enzyme inhibitors (1 pellet/25 ml, Boehringer Mannheim) and 1 mg/ml lysozyme. The bacterial suspensions were sonicated and centrifuged at 45,000 rpm for 1 h. The clear supernatants were applied to 2 ml Ni-NTA Agarose columns (QIAGEN) equilibrated with lysis buffer. Columns were washed with 10 column vol of wash buffer (50 mm sodium phosphate, 300 mm NaCl, 20 mm imidazole, pH 8.0), and the bound proteins were eluted with 5 column vol of elution buffer (50 mm sodium phosphate, 300 mm NaCl, 250 mm imidazole, pH 8.0). Eluted proteins were concentrated using Amicon Centricon filters (Amicon, Beverly, MA).
Enzyme assays
For determination of substrate specificity, an equimolar mixture of DHEA, cholesterol, and oxysterol was prepared by solubilization in 3 mm (final concentration) hydroxypropyl-␤-cyclodextrin (38) . The incubation mixture consisted of 20 m each of DHEA, cholesterol, and an oxysterol [24(S)-, 25-, or 27-hydroxycholesterol], 100 m [
35 S]PAPS, and either 27 g HST1 or 13.6 g of an HST2a or 2b isoform in a total vol of 0.1 ml 100 m Tris-HCl (pH 7.1) and 5 mm magnesium acetate. Reactions were stopped at 30 min, by the addition of 1 ml chloroform, and the free alcohols and sulfoconjugates were extracted into chloroform by complexing with methylene blue (39) . The chloroform layer was backwashed 4 times with 1 ml water to remove unreacted [
35 S]PAPS. The chloroform was taken to dryness and redissolved in 0.1 ml methanol, for analysis by HPLC and gradient elution.
HPLC analysis
A model no. 1100 instrument (Hewlett-Packard Co.), equipped with a diode array detector, set to absorb at 202 Ϯ 20 nm, was used. Samples were injected onto an Aqua 3_C18 reverse phase column, 150 ϫ 4.6 cm (Phenomenex, Torrance, CA). An initial trinary solvent system of acetonitrile, methanol, and water (5:55:45), each containing 1.0 ml of 7.4 m ammonium acetate/liter (40) , was used, with an initial flow rate of 0.5 ml/min. During a 25-min period, the flow rate and solvent system changed linearly to 1.5 ml/min and 5:95:0, respectively, and this was followed by an additional isocratic period of 15 min, for a total duration of 40 min. Fractions were collected at intervals of either 0.5 or 1.0 min, and the total counts-per-minute in each fraction was determined by liquid scintillation spectrometry at constant efficiency.
RT-PCR analysis
RT was performed using the ThermoScript RT-PCR system, according to the manual provided by the company (Life Technologies, Inc.). Briefly, in one reaction tube, the first cDNA strand was synthesized at 50 C for 60 min using 3 g of total RNA as template and the gene-specific antisense primers, 5Ј-TTCTCCTCTCTCATGGGCATCCAGCCATG-3Ј for HST1 and 5Ј-TCCAGGATGGATCCCCTTCCTTCAGGATTAAG-3Ј for both HST2a and HST2b. cDNAs were amplified by PCR using 2 l cDNA reaction mix as template and gene-specific primer pairs: HST1, 5Ј-CGTGATGAGTTCGTGATAAGGGATGAAGATG-3Ј (sense primer) and 5Ј-TGTGGTCAAACCATGACCCATATAGCACAG-3Ј (antisense primer); HST2a, 5Ј-GTGTCACCACTTTACAGAAGAGGGACTGAG-3Ј (sense primer) and 5Ј-AGATGATCTCGATCATCCAGGTCGTGC-CGT-3Ј (antisense primer); and HST2b, 5Ј-GGCTTGTGGGACAC-CTATGAAGATGACATC-3Ј(senseprimer),5Ј-AGATGATCTCGATCA-TCCAGGTCGTGCCTG-3Ј (antisense primer). PCR conditions were: initial denaturation at 94 C for 2 min, followed by 40 cycles of 30 sec at 94 C, 30 sec at 60 C, and 30 sec at 72 C.
Results
As shown in Fig. 1 , the sulfonates of DHEA, 27-hydroxycholesterol, and cholesterol were clearly resolved by HPLC; and although individual oxysterol monosulfonates could not be adequately resolved from each other, they were completely resolved as monosulfonate/monoacetate derivatives. Table 1 gives a listing of the retention times for all compounds analyzed.
SDS analysis of the overexpressed and purified proteins revealed that HST1 and the HST2 isoforms were 90 -95% and 85-90% pure, respectively (data not presented). Because no statistical differences among the three oxysterols examined were found (data not presented), we have opted to use 27-hydroxycholesterol as the representative oxysterol. The relative ability of the three human HST enzyme preparations to sulfonate DHEA, cholesterol, and 27-hydroxycholesterol is illustrated in Fig. 2 . In the presence of an equimolar amount of DHEA, the C 27 sterols accounted for 88 and 97% of the sulfonates formed with HST2a and HST2b, respectively (Fig.  2) . On the other hand, DHEA was primarily sulfonated by HST1. It is also noteworthy that HST1 sulfonated cholesterol only minimally (ϳ2%), whereas cholesterol sulfonation rose to 13% with HST2a, and 48% with HST2b. To obtain an easily detectable rate for cholesterol sulfonation, the protein concentration used for HST1 was generally double that of the HST2 isoforms. The striking difference in cholesterol sulfonation is reflected in the HST-specific activities: HST1, 0.01 pmol/min⅐mg protein; HST 2a, 0.62 pmol/min⅐mg protein; and HST2b, 0.83 pmol/min⅐mg protein.
Aliquots of [ 35 S]-labeled 27-hydroxycholesterol sulfonate (prepared using either HST2a or HST2b), fractionated by HPLC, were acetylated and reanalyzed by HPLC. Importantly, all of the radioactivity was contained in a single fraction corresponding to an identical retention time to that of the 27-hydroxycholesterol 3-sulfonate 27-acetate standard (Fig.  3) . It should also be noted that standards for the 3-sulfonate 27-acetate and 3-acetate 27-sulfonate derivatives of 27-hydroxycholesterol were clearly resolved by HPLC (Fig. 3) . In other studies, it was found that no sulfonates were formed with the 3-acetates of 24(S)-, 25-, or 27-hydroxycholesterol using either of the HST2 isoforms (data not shown).
RT-PCR analysis revealed distinct patterns of tissue expression of HST1, HST2a, and HST2b. HST1 was highly expressed in the adrenal, colon, ovary, prostate, small intestine, stomach, and liver; minimal expression was noted for bone marrow, brain, kidney, placenta, spleen, thymus, and thyroid (Fig. 4) . Expression of HST1 was barely detectable in the bone marrow and spleen, and no expression was noted for lung and skin. HST2a was clearly expressed in the placenta, prostate, and skin and (to a lesser extent) in the kidney, lung, ovary, and small intestine (Fig. 4) . In contrast to HST2a, expression of HST2b was ubiquitous, with expression being most prominent in the colon, kidney, lung, placenta, prostate, 13 .6 g of an HST2a or 2b isoform in a total vol of 0.1 ml. The height of individual bars represents the percent of total recoverable radioactivity incorporated into each sulfonated product.
skin, small intestine, stomach, thymus, and thyroid; expression was clearly less in the adrenal, ovary, spleen, and liver and barely detectable in the bone marrow and brain (Fig. 4) .
Discussion
Human HST2a and HST2b were cloned using a probe containing a highly conserved sulfotransferase motif suitable for searching an expressed sequence tag database (34) . The search resulted in the identification of an expressed tag located at the 3Ј-end of a clone isolated from a human placental cDNA library by the IMAGE Consortium. This resulted in the cloning of two cDNAs, differing only at their 5Ј-termini. The cDNA for human HST1, which was originally cloned using liver (30 -32) and fetal adrenal (33) RNA, is commonly referred to as DHEA sulfotransferase, because DHEA is the preferred substrate. HST1, however, has broad substrate specificity and will sulfonate C 21 (pregnenolone), C 19 (testosterone), and C 18 (estradiol) steroids (41, 42) , as well as C 27 cholesterol (43) and C 24 bile acids (44) . This is in contrast to the more recently cloned HST2a and HST2b, which, though they do sulfonate DHEA, do not sulfonate estrogens and simple phenols (34); they also do not sulfonate testosterone or bile acids (our unpublished data). It was further reported that the HST2 isoforms sulfonate DHEA, with apparent K m values for DHEA that are similar to that of HST1 (34) . Based on this finding plus the observation that HST2a and HST2b do not sulfonate estrogens and simple phenols, it was concluded that these enzymes should be considered to be members of the HST subfamily of soluble sulfotransferases (34) . This conclusion notwithstanding, however, the HST2 isoforms are structurally distinct at the amino-and carboxytermini from all previously cloned HST proteins (vide infra).
Because human HST2a and HST2b are structurally unique vis-à-vis other soluble C 18 , C 19 , and C 21 steroid sulfotransferases, we were interested in examining their reactivity against the larger C 27 sterols, i.e. cholesterol and its hydroxylated metabolites, particularly because a specific sulfotransferase had not been identified for either cholesterol or oxysterols. For this purpose, it was necessary to develop a chromatographic system that could separate the different products generated by an enzyme when using multiple substrates in combination. Based on our previous studies (38) and those of others (45), we used the capacity for watersoluble hydroxypropyl-␤-cyclodextrin to include sterols within the torus and thus maintain nonpolar compounds in solution. Because several studies have documented the usefulness of hydroxypropyl-␤-cyclodextrin in enhancing catalytic rates with cholesterol as a substrate (46, 47) , it can be concluded that the differences observed in these studies properly reflect the relative affinity of a substrate for a specific HST, rather than access to the enzyme because of a difference in solubility.
We are not aware of previous studies of oxysterol sulfonate formation. Although our studies do not exclude the possibility that other naturally occurring sulfonate derivatives of oxysterols may exist, we can be certain that the human HST2 enzymes generated 3-sulfonate metabolites. Previous studies had established the existence of endogenously occurring sulfonates of 27-hydroxycholesterol (9) and 24S-hydroxycholesterol (10, 11) . In the latter reports, however, the methods used were based on derivative analysis after cleavage of the sulfonate moiety. Therefore, no direct structural information was possible, although a 3-sulfonate structure could be deduced. In our studies, the direct determination of the sulfonate product formed by the HST enzymes permitted a definitive assignment of the sulfonate moiety to only the 3␤-hydroxyl group of the sterol. Furthermore, stereospecificity involving the 3-hydroxyl group was maintained by the inability of the HST2 isoforms to sulfonate lithocholic acid whose 3-hydroxyl group is ␣-oriented (data not presented).
All previously cloned members of the soluble sulfotransferase superfamily, i.e. estrogen and phenol sulfotransferases and HSTs, have sizes that range from 282-295 amino acids (48 -50) . Therefore, a principal difference between the HST1 and HST2 isoforms relates to their respective sizes. HST1 contains 285 amino acids, whereas HST2a and HST2b consist of 350 and 365 amino acids, respectively (see Fig. 5 ). Interestingly, the sizes of the HST2 isoforms are more closely aligned with members of the larger Golgi membrane-associated class of sulfotransferases (51) (52) (53) (54) . Although it is assumed that the HST2 isoforms are soluble and not membrane-associated, this has not been definitively demonstrated. The increase in size of the human HST2 isoforms is attributable primarily to their extended amino-and carboxyterminal ends; otherwise, a significant structural similarity between the HST1 and HST2 proteins in their core regions is present (see Fig. 5 ). Furthermore, P-loop motifs (55) (56) (57) and specific amino acid residues important in protein-cofactor interaction of soluble sulfotransferases (57) are completely conserved.
The functional significance of the extended amino-and carboxyterminal ends of the HST2 isoforms is not known (cf. Fig. 5 ). The aminoterminal ends do not seem to contain a signal sequence (58) , and their amino acid sequences do not suggest an integral membrane protein (59) . The aminoterminus of the HST2a isoform contains a proline-dominated motif (SPPPF) suggestive of a motif that serves as a binding site for proteins containing WW domains (60) . The prominence of proline residues is most striking in the carboxyterminal ends of the HST2 proteins, which are proline-enriched (see Fig. 5 ). This is significant because proline-rich regions of proteins, which occur widely in prokaryotes and eukaryotes and are commonly located in the C-termini of proteins, are involved in protein-protein interactions (61) . Additionally, the carboxyterminal ends of the HST2 proteins are enriched not only in proline but also glutamic acid, serine, and threonine suggestive of polypeptide sequences that target proteins for rapid degradation by the 26S proteasome (62) . It is to be noted that a structurally related novel HST has also been cloned in the mouse (63) .
Another significant difference among HST1, HST2a, and HST2b was that their messenger RNA (mRNA) expression patterns were clearly distinct. HST1 was relatively highly expressed in steroidogenic organs (adrenal and ovary), androgen-dependent tissue (prostate), tissues of the alimentary tract (stomach, small intestine, and colon), and the liver. Presumably, reflecting a greater sensitivity, expression of HST1 by RT-PCR was more extensive than previous studies employing Northern analysis would suggest, i.e. the latter demonstrated HST1 expression in only the adrenal (64), liver (64, 65) , and small intestine (65) . Additionally, HST1 protein and mRNA have been localized to parietal cells in human gastric mucosa (66) . Similar to HST1, Northern analysis of HST2 revealed only limited expression involving the placenta, prostate, trachea, and small intestine (34) . Furthermore, the latter study did not distinguish between HST2a and HST2b (34) . The RT-PCR expression patterns of HST2a and HST2b were distinct from each other, in that HST2b was clearly more widely expressed than the HST2a isoform. A notable distinction among the RT-PCR expression patterns of HST1, HST2a, and HST2b was the lack of HST1 expression in skin, an organ where the HST2 isoforms were highly expressed.
Based on the substrate specificity results, we would suggest that the HST2 isoforms, in contrast to HST1, are the sulfotransferases that normally sulfonate cholesterol and its hydroxylated metabolites. Tissue expression patterns also support this judgment, in that skin expresses only the HST2 isoforms and not HST1. Sulfonation of cholesterol, an important metabolic step during normal skin development and creation of the barrier, has been subject to extensive investigation. Normally, cholesterol is sulfonated in the living epidermis; the cholesterol sulfonate then accumulates in the stratum corneum, where it undergoes sulfohydrolysis, creating a phenomenon that has been termed the epidermal cholesterol sulfate cycle (27) . The fact that the normal cholesterol/cholesterol sulfonate ratio in blood and gastrointestinal epithelia is approximately 500:1, whereas in the normal stratum corneum the ratio is 5-10:1 suggests that regulation of this ratio may be critical to normal desquamation (67) . Differentiation of normal human epidermal keratinocytes is accompanied by an accumulation of cholesterol sulfonate, which is accounted for by an increase in cholesterol sulfotransferase activity (68) . Epidermal cornification involves the cross-linking of precursor proteins, a process dependent on the activity of transglutaminase 1, which in turn is dependent on the accumulation of cholesterol sulfonate, a transcriptional activator of the transglutaminase 1 gene (69) .
Abnormalities in the metabolism of 24(S)-hydroxycholesterol and 27-hydroxycholesterol have been associated with different diseases. Accelerated atherosclerosis is a wellrecognized sequela in some individuals lacking 27-hydroxycholesterol on a genetic basis (70) . In others, only neurological abnormalities occur, which range from severe mental retardation to peripheral neuropathies (70) . A disturbance in 24(S)-hydroxycholesterol metabolism has recently been reported in Alzheimer's disease (71) . It is of particular interest that the genes coding for the P 450 hydroxylase enzymes that convert cholesterol to these oxysterols are expressed in the central nervous system (7, 72) and that a sulfonated ester of 24(S)-hydroxycholesterol is a constituent of normal brain tissue (20) . The protean manifestations that occur with disturbances in these metabolic pathways indicate that further insights into disease mechanisms can only be obtained from detailed knowledge of the interrelationships of the biological effects of these oxysterols and their sulfonated esters.
